Search
Close this search box.
    • Small Molecules
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Search
Close this search box.

Cytochrome P450 Induction

Cytochrome P450 Induction

Evaluating the metabolism of test compounds

Syngene offers a suite of validated and efficient cytochrome P450 (CYP) induction assays that provide valuable insights into the metabolism of test compounds. These assays are designed to help clients make informed drug development decisions based on the efficacy and safety profiles of a drug candidate.

Syngene scientists estimate the potential clearance pathways for test compounds through CYP reaction phenotyping methods that use chemical inhibitors in human liver microsomes. The involvement of multiple pathways helps us measure the extent of CYP metabolism-based drug-drug interactions.

Capabilities

Our scientists have vast expertise across all CYP isoforms that enable them to quickly identify strategies to advance a client’s pipeline. Our teams have a strong track record in delivering robust and reliable results, access to best-in-class facilities, and consistently uphold data integrity and client confidentiality in all projects.

The CYP induction assays that we offer include:

  • HepG2 cell line (CYP3A4): Reporter gene-based assay
  • Human hepatocytes

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details